Cargando…
Comments on “dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750810/ https://www.ncbi.nlm.nih.gov/pubmed/36288468 http://dx.doi.org/10.1111/1759-7714.14710 |
| _version_ | 1784850338582364160 |
|---|---|
| author | Wang, Shan‐Ying Shiau, Yu‐Chien Hsu, Chen‐Xiong |
| author_facet | Wang, Shan‐Ying Shiau, Yu‐Chien Hsu, Chen‐Xiong |
| author_sort | Wang, Shan‐Ying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9750810 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97508102022-12-15 Comments on “dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” Wang, Shan‐Ying Shiau, Yu‐Chien Hsu, Chen‐Xiong Thorac Cancer Letter to the Editor John Wiley & Sons Australia, Ltd 2022-10-26 2022-12 /pmc/articles/PMC9750810/ /pubmed/36288468 http://dx.doi.org/10.1111/1759-7714.14710 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Wang, Shan‐Ying Shiau, Yu‐Chien Hsu, Chen‐Xiong Comments on “dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| title | Comments on “dynamic
(18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| title_full | Comments on “dynamic
(18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| title_fullStr | Comments on “dynamic
(18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| title_full_unstemmed | Comments on “dynamic
(18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| title_short | Comments on “dynamic
(18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| title_sort | comments on “dynamic
(18)f‐fdg pet/ct can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750810/ https://www.ncbi.nlm.nih.gov/pubmed/36288468 http://dx.doi.org/10.1111/1759-7714.14710 |
| work_keys_str_mv | AT wangshanying commentsondynamic18ffdgpetctcanpredictthemajorpathologicalresponsetoneoadjuvantimmunotherapyinnonsmallcelllungcancer AT shiauyuchien commentsondynamic18ffdgpetctcanpredictthemajorpathologicalresponsetoneoadjuvantimmunotherapyinnonsmallcelllungcancer AT hsuchenxiong commentsondynamic18ffdgpetctcanpredictthemajorpathologicalresponsetoneoadjuvantimmunotherapyinnonsmallcelllungcancer |